• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=20406486).
  

PubMed=20406486; DOI=10.1186/1479-5876-8-39; PMCID=PMC2876068
Jonas Norskov Sondergaard, Ramin Nazarian, Qi Wang, De-Liang Guo, Teli Hsueh, Stephen Mok, Hooman Sazegar, Laura E. MacConaill, Jordi Ginesta Barretina, Sarah M. Kehoe, Narsis Attar ...Show all 19 authors... , Erika Maria von Euw, Jonathan E. Zuckerman, Bartosz Chmielowski, Begonya Comin-Anduix, Richard C. Koya, Paul Salomon Mischel, Roger S. Lo, Antoni Ribas; Show fewer authors
Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.
J. Transl. Med. 8:39.1-39.11(2010)

PubMed=20689758; DOI=10.1593/neo.10414; PMCID=PMC2915408
William Douglas Tap, Ke-Wei Gong, Judy Dering, Yiou Tseng, Charles Ginther, Giovanni Pauletti, John A. Glaspy, Richard Essner, Gideon Bollag, Peter Hirth, Chao Zhang, Dennis Joseph Slamon;
Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.
Neoplasia 12:637-649(2010)